Dun & Bradstreet (DNB) began trading on the NYSE on Wed 1 July 20

Dun & Bradstreet Holdings, Inc. provides business decisioning data and analytics in North America and internationally.   Dun & Bradstreet Holdings, Inc. is a subsidiary of Star Parent L.P.

• Sector: Technology
• Industry: Information Technology Services
• Full Time Employees: 4,037
• Founded in 1841 
• HQ in Short Hills, New Jersey
• http://www.dnb.com

Dun & Bradstreet priced upsized 78.3 mln share IPO at $22, above the $19-$21 expected price range

• The IPO was originally expected to consist of 65.75 mln shares.
• The lead underwriters on the IPO were Goldman Sachs, BofA Securities, JP Morgan, and Barclays.

IPOs this week : June 29 - July 2, 20 (wk 26)

IPOs expected to price

• DoubleDown Interactive (NASDAQ:DDI) and Dun & Bradstreet (NYSE:DNB) on June 30, as well as 
• Accolade (NASDAQ:ACCD) and Lemonade (NYSE:LMND) on July 1. 

IPO quiet period expirations

• Warner Music Group (NASDAQ:WMG) and Pliant Therapeutics (NASDAQ:PLRX) on June 29, as well as 
• ZoomInfo (NASDAQ:ZI), Applied Molecular (NASDAQ:AMTI) and Shift4 Payments (NYSE:FOUR) on June 30. 

All five of those stocks have rallied since their debut, from Warner Music's 22% gain to ZoomInfo's 142% pop.

IPO lockup expirations

• Northstar Gold (OTCPK:NSGCF). 

Across the Pacific, IPO debuts for Kangji Medical ($404M), Gan & Lee Pharmaceuticals ($360M) and Hygeia Healthcare ($286M) are on tap.

Dun & Bradstreet (DNB) announces launch of 65.75 mln share IPO

Expected to price between $19-$21

• The lead underwriters on the IPO are Goldman Sachs, BofA Securities, J.P. Morgan, and Barclays.
• DNB has applied to list shares on the NYSE.
• A subsidiary of Cannae (CNNE), a subsidiary of Black Knight (BKI), and a subsidiary of CC Capital Partners plan to invest $200.0 mln, $100.0 mln, and $100.0 mln, respectively, in a concurrent private placement of DNB's common stock that is contingent upon the consummation of the offering at a price per share equal to 98.5% of the initial public offering price.
• DNB intends to use the proceeds that it receives from the offering and the concurrent private placement to redeem all of its outstanding Series A Preferred Stock, repay a portion of its 10.250% Senior Unsecured Notes outstanding due 2027 and for working capital and other general corporate purposes.